Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
Location status: Recruiting
NCT Number: NCT06206863
This clinical trial evaluates a community-based physical activity program for underserved cancer survivors. Cancer and its treatment significantly influence physical, psychosocial, and cognitive functioning. Historically, community sites (local and national) have not been staffed to offer support services such as physical, and occupational therapies (everyday life activities to promote health and well-being) or nutrition counselling, and do not offer a whole-person model of care. In this study, researchers have partnered with the YMCA to provide tailored home-based exercise programs for underserved cancer patients and survivors. Accessing exercise professionals may allow patients to prevent acute problems from becoming chronic, long-lasting physically weak impairments that directly influence patients' quality of life.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Buffalo, New York, 14263, United States
Location status: Recruiting
PRIMARY OBJECTIVE:
I. To assess the feasibility and acceptability of a community-based 12-week physical activity intervention.
SECONDARY OBJECTIVE:
I. To assess the effectiveness of a virtual physical activity intervention by evaluating pre-post changes in quality of life (QoL).
EXPLORATORY OBJECTIVE (OPTIONAL):
I. To virtually assess changes in functional performance in a small subgroup.
OUTLINE:
Participants participate in virtual exercise classes at least three times a week (TIW) over 20-60 minutes for 12 weeks. Participants are expected to work towards achieving the national physical activity exercise guidelines of 150 minutes of moderate intensity aerobic based physical activity and 2-3 strength training sessions each week.
After completion of study intervention, patients are followed up at 1 week.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participate in virtual exercise classes
Ancillary studies
Time frame: Up to 12 weeks
At the provider level, feasibility will be defined as the proportion of patients that were referred to the intervention versus (vs.) the proportion of patients that enrolled in the study. Will estimate the referral rates with 95% confidence intervals obtained from generalized estimating equation (GEE) logistic regression models, accounting for the within provider clustering.
Time frame: Up to 12 weeks
At the provider level, feasibility will be defined as the proportion of patients that were referred to the intervention vs. the proportion of patients that enrolled in the study.
Time frame: At the end of the 12-week intervention
At the patient level, feasibility will be defined as the proportion of patients still on study. Will estimate with 95% confidence intervals obtained from GEE logistic regression models, accounting for the within provider clustering.
Time frame: At post 12-weeks
Adherence will be defined as the percentage of patients on study after 12-weeks who complete at least 70% of the intervention videos. Will estimate with 95% confidence intervals obtained from GEE logistic regression models, accounting for the within provider clustering.
Time frame: Up to 12 weeks
Acceptability will be determined by measuring adherence to the intervention and by measuring patient satisfaction. Patient satisfaction will be determined through pre-post intervention surveys. Will use the appropriate generalized linear model (ex. linear or logistic), as determined by the question type and accounting for the within provider clustering.
Time frame: Up to 12 weeks
Will assess the changes in physical functioning, sustained physical activity, and quality of life using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30) score.
Roswell Park Cancer Institute
Other
Community-Based Physical Activity Across the Cancer Continuum
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04494945
Adenocarcinoma, Adnexal Diseases
Portland, Oregon, United States
View Trial DetailsNCT06015932
Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
Rochester, Minnesota, United States
View Trial DetailsNCT06314672
Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
Columbus, Ohio, United States
View Trial DetailsNCT06246955
Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
Scottsdale, Arizona, United States
View Trial Details